Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012:8:597-605.
doi: 10.3762/bjoc.8.66. Epub 2012 Apr 18.

2-Allylphenyl glycosides as complementary building blocks for oligosaccharide and glycoconjugate synthesis

Hemali D Premathilake  1 , Alexei V Demchenko
Affiliations

2-Allylphenyl glycosides as complementary building blocks for oligosaccharide and glycoconjugate synthesis

Hemali D Premathilake et al. Beilstein J Org Chem. 2012.

Abstract

The O-allylphenyl (AP) anomeric moiety was investigated as a new leaving group that can be activated for chemical glycosylation under a variety of conditions, through both direct and remote pathways. Differentiation between the two activation pathways was achieved in a mechanistic study. The orthogonal-type activation of the AP moiety along with common thioglycosides allows for the execution of efficient oligosaccharide assembly.

Keywords: carbohydrates; glycosylation; leaving group; oligosaccharides; orthogonal strategy; selective activation.

PubMed Disclaimer

Figures

Scheme 1
Scheme 1
Orthogonal strategy introduced by Ogawa et al.
Scheme 2
Scheme 2
Determination of the AP activation pathways.
Scheme 3
Scheme 3
AP building blocks in oligosaccharide synthesis.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Varki A, Cummings R D, Esko J D, et al. Essentials of Glycobiology. New York: CSH Press; 2009. - PubMed
    1. Witczak Z J. Carbohydrates as new and old targets for future drug design. In: Witczak Z J, Nieforth K A, editors. Carbohydrates in Drug Design. New York: Marcel Dekker Inc.; 1997. pp. 1–37.
    1. Wong C-H, editor. Carbohydrate-Based Drug Discovery. Weinheim: Wiley-VCH; 2003. - DOI
    1. Klyosov A A, Witczak Z J, Platt D, editors. Carbohydrate Drug Design. Vol. 932. Washington: ACS; 2006. ((ACS Symposium Series)). - DOI
    1. Zhu X, Schmidt R R. Angew Chem, Int Ed. 2009;48:1900–1934. doi: 10.1002/anie.200802036. - DOI - PubMed